Medtronic Spine announced that it will be completing the study of Aperius PercLID by October 2015.
Aperius Percutaneous Lumbar Interspinous Decompression system (PerLID) is used for the treatment of Lumbar Spinal Stenosis. An expandable device, the Aperius implant is percutaneously placed between the spinous processes, and then expanded in place, to end in a position. In its expanded state, the Aperius implant is designed to stay in place, and not to migrate. Aperius technology is intended to further simplify the treatment of LSS.
The objective of the study is to provide clinical evidence proving that the Aperius PercLID System is safe and non-inferior to standalone decompressive surgery with regards to clinical outcomes in patients suffering from Degenertive Lumbar Spinal Stenosis with Neurogenic Intermittent Claudication, relieved by flexion.
The 40 patient study is not yet open for participant recruitment. The official title of the study is “Comparison of Healing Responses After Treatment of Complex Bifurcation Lesions With the AXXESS Biolimus A9 Eluting Stent Versus Culotte Technique Using Everolimus-Eluting Stents: an Optical Coherence Tomography Analysis”.